DiviDrip · ELTX

ELTX — Elicio Therapeutics, Inc.

ELTX is Elicio Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.41. Market cap: $63M. Capital Quality Rank: 13/100 — Capital destroyer.

Stock snapshot

Price$2.41
Market cap$63M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)13 / 100 · Capital destroyer
Shareholder buyback yield-20.31%
Altman Z-score zoneDistress

About ELTX

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Listed2023Employees33HQBoston, MASectorHealthcareWebsiteelicio.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ELTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ELTX's current stock price?

ELTX (Elicio Therapeutics, Inc.) is currently trading at $2.41.

Does ELTX pay a dividend?

ELTX (Elicio Therapeutics, Inc.) does not currently pay a regular dividend.

What is ELTX's Capital Quality Rank?

ELTX has a Capital Quality Rank of 13/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ELTX in DiviDrip

Add ELTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-08. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow